Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Common Links
U.S. Food & Drug Administration
Follow FDA
En Español
Search FDA
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
New Pediatric Labeling Information Database - Detail
FDA Home
Pediatrics
New Pediatric Labeling Information Database
Detail
-
Please note:
JavaScript must be enabled for this application to work properly.
Check your settings
if you are unsure if your JavaScript is enabled.
Pediatric Labeling Date:
03/30/2001
Trade Name:
Ultane
Generic Name or Proper Name (*):
sevoflurane
Indications Studied:
Induction and maintenance of general anesthesia
Label Changes Summary:
New study in pediatric patients 9 days-12 years comparing sevoflurane and halothane Precautions section and Adverse Events During Post-Marketing subsection updated to add information on the rare cases of seizures that have been reported in pediatric patients in association with sevoflurane use. The majority of cases were in children and young adults, most of whom had no medical history of seizures Pediatric information consolidated into new Pediatric Use subsection
Product Labeling:
Labeling
BPCA(B):
B
Sponsor:
Abbott
Pediatric Exclusivity Granted Date:
08/02/2000
NNPS:
FALSE'
Therapeutic Category:
Anesthetic agent
-
-